Stockscreener 앱 받기
4.19
0.48%
0.02
시간 외 거래:
4.19
전일 마감가:
$4.17
열려 있는:
$4.17
하루 거래량:
2.20M
Relative Volume:
0.85
시가총액:
$361.68M
수익:
$103.00K
순이익/손실:
$-42.47M
주가수익비율:
-2.2053
EPS:
-1.9
순현금흐름:
$-34.30M
1주 성능:
+0.96%
1개월 성능:
+3.71%
6개월 성능:
+11.73%
1년 성능:
+127.72%
1일 변동 폭
$4.164
$4.19
1주일 범위
$4.15
$4.20
52주 변동 폭
$1.75
$4.50
Checkpoint Therapeutics Inc Stock (CKPT) Company Profile
명칭
Checkpoint Therapeutics Inc
전화
781-652-4500
주소
95 SAWYER ROAD, WALTHAM, NY
CKPT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CKPT
Checkpoint Therapeutics Inc
|
4.19 | 361.13M | 103.00K | -42.47M | -34.30M | -1.90 |
|
ONC
Beigene Ltd Adr
|
241.43 | 24.41B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
436.00 | 111.55B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.335 | 42.47M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
588.34 | 63.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
75.06 | 5.92B | 0 | -153.72M | -103.81M | -2.00 |
Checkpoint Therapeutics Inc Stock (CKPT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-13 | 개시 | D. Boral Capital | Buy |
| 2022-07-14 | 재개 | B. Riley Securities | Buy |
| 2021-06-09 | 개시 | B. Riley Securities | Buy |
| 2021-01-20 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-05-29 | 개시 | Lake Street | Buy |
| 2017-12-08 | 개시 | H.C. Wainwright | Buy |
모두보기
Checkpoint Therapeutics Inc 주식(CKPT)의 최신 뉴스
Checkpoint Therapeutics Announces Merger Progress - Investing.com
Checkpoint Therapeutics Announces Merger Progress By Investing.com - Investing.com India
Checkpoint Therapeutics Merger Awaits Stockholder Vote - TipRanks
Cancer Drug Co. Beats Investor Suit Over FDA Rejection - Law360
Checkpoint Therapeutics Beats Investor Suit Over FDA Assent (1) - Bloomberg Law News
Balyasny Asset Management L.P. Buys New Stake in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Stifel Financial Corp Acquires New Holdings in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - The Manila Times
Fortress Biotech Earnings: Triple Win with $28M Checkpoint Deal, FDA Fast-Track, and Rosacea Drug Launch - Stock Titan
Lake Street Keeps Their Hold Rating on Checkpoint Therapeutics (CKPT) - The Globe and Mail
Tower Research Capital LLC TRC Acquires 6,486 Shares of Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates - GlobeNewswire
Checkpoint Therapeutics Secures $416M Merger Deal After Landmark FDA Cancer Drug Approval - Stock Titan
Envestnet Asset Management Inc. Has $214,000 Holdings in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Tecsys Placed as a Challenger in 2025 Gartner® Magic Quadrant™ for Warehouse Management Systems - The Globe and Mail
Marshall Wace LLP Decreases Stake in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Checkpoint Therapeutics (CKPT) Expected to Announce Earnings on Friday - Defense World
Microsoft’s Stock Rises 9% As Financial Results Top Estimates - The Globe and Mail
CHECKPOINT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkpoint Therapeutics, Inc.CKPT - marketscreener.com
Press Release Distribution & PR Platform - ACCESS Newswire
AppTech Unveils Revolutionary CoreBanking Solution, Projecting Explosive Growth with Innovative Client Offerings - The Globe and Mail
Sun Pharma shares in focus as co to acquire Checkpoint Therapeutics for $355 million - MSN
2025-04-19 | SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, CKPT, QTRX, AKYA on Behalf of Shareholders | NDAQ:CKPT | Press Release - Stockhouse
$TOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The MergerBRDG, AKYA, CKPT, QTRX - Longview News-Journal
3 Leading Tech Stocks to Buy in 2025 - The Globe and Mail
Checkpoint therapeutics CFO Garrett Gray sells $49,904 in stock By Investing.com - Investing.com South Africa
High Growth Tech Stocks in the US for April 2025 - simplywall.st
3 Growth Companies Insiders Are Betting On - Yahoo Finance
Checkpoint Therapeutics CEO sells stock for $60,963 By Investing.com - Investing.com Canada
Checkpoint therapeutics CFO Garrett Gray sells $49,904 in stock - Investing.com India
Checkpoint Therapeutics Executives Sell Shares for Tax Obligations - TradingView
Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights - The Manila Times
Fortress Biotech Transforms Portfolio: Dual FDA Wins, $28M Deal, Latest Earnings - Stock Titan
Checkpoint Therapeutics Full Year 2024 Earnings: US$1.42 loss per share (vs US$1.87 loss in FY 2023) - Yahoo Finance
Checkpoint Therapeutics Reports 2024 Financial Results and Merger - TipRanks
Checkpoint Therapeutics Inc. (CKPT) reports earnings - Quartz
Checkpoint Therapeutics, Inc. SEC 10-K Report - TradingView
Checkpoint Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates - The Manila Times
Breakthrough: CKPT Secures FDA Approval and $416M Merger Deal in Transformative Year - Stock Titan
GLAZER CAPITAL, LLC Acquires Significant Stake in Checkpoint Therapeutics Inc - GuruFocus
Beryl Capital Management LLC's Strategic Acquisition of Checkpoi - GuruFocus.com
GLAZER CAPITAL, LLC Acquires Significant Stake in Checkpoint The - GuruFocus
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, CMRX, WBA, CKPT on Behalf of Shareholders - Morningstar
Checkpoint Therapeutics, Inc.'s (NASDAQ:CKPT) Shift From Loss To Profit - Yahoo
Sun Pharma To Acquire Nasdaq-Listed Checkpoint Therapeutics For $355 Million - MSN
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) Buyout Offer and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options - GlobeNewswire
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of ... - Bluefield Daily Telegraph
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) Buyout Offer and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options - GlobeNewswire Inc.
10,081 Shares in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Bought by SBI Securities Co. Ltd. - Defense World
Sun Pharma is betting big on speciality. Will it pay off? | Stock Market News - Mint
Checkpoint Therapeutics Inc (CKPT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
17.27%
1.06%
자본화:
|
볼륨(24시간):